Market Tracker

05/26 5:16pm ET

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.56
Delayed Data
As of May 25
 0.00 / 0.00%
Today’s Change
1.93
Today|||52-Week Range
7.85
-19.30%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.56
Today’s openn.a.
Day’s range-- - --
Volume163
Average volume (3 months)90,217
Market cap$13.2M
Dividend yield--
Data as of 05/25/2017

Growth & Valuation

Earnings growth (last year)+35.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.62

Competitors

 Today’s
change
Today’s
% change
CYANCyanotech Corp-0.10-2.74%
ATOSAtossa Genetics Inc-0.02-4.04%
ISRIsoRay Inc+0.01+1.68%
IBIOIbio Inc+0.00+0.16%
Data as of 4:02pm ET, 05/26/2017

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$2.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts